Open Beta
MetriLume

US marketsHSCS

SEC-sourced researchBeta

HSCS

HeartSciences Inc.

Company comparison ↗

Data passport

CIK
0001468492
Exchange
Nasdaq
Business activity
— · SIC 3842
Financial inputs
3/6
Filing date
Oct 6, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: April 2025: 4,350.0000 USD; December 2025: — USD; April 2026: 4,319.0000 USD4.4K USD0 USD0April 2025December 2025April 2026
HSCS · Exact amounts and source periods · USD
Period endRevenueFiling date
April 20254,350.0000Jul 23, 2026
December 2025No dataJul 23, 2026
April 20264,319.0000Jul 23, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
April 20264,319.0000-9,141,875.0000-7,426,707.0000——Jul 23, 2026
December 2025———4,222,909.00004,017,738.0000Jul 23, 2026
April 20254,350.0000-8,765,229.0000-7,412,994.0000——Jul 23, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$4.32KApril 2026Jul 23, 202610-K
Previous period revenue————
Net incomeNetIncomeLoss-$9.14MApril 2026Jul 23, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$7.43MApril 2026Jul 23, 202610-K
Total assets————
Total liabilities————

New filings

Explore methodology ↗